mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior

Neuropsychopharmacology

Volumn 29, Issue 5, 2004, Pages 921-928

  Bäckström, Pia ^a   Bachteler, Daniel ^b   Koch, Sabrina ^b   Hyytiä, Petri ^a   Spanagel, Rainer ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alcohol deprivation effect; Discriminative stimulus; Ethanol priming; mGluR5; MPEP; Reinstatement

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ALCOHOL; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; ATTENUATION; COMPETITIVE INHIBITION; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE; TRAINING;

ALCOHOL DRINKING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PYRIDINES; RATS; RATS, LONG-EVANS; RECEPTORS, METABOTROPIC GLUTAMATE; RECURRENCE; SELF ADMINISTRATION;

EID: 9644272348     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300381     Document Type: Article

References (48)

1. Bienkowski P, Koros E, Kostowski W, Bogucka-Bonikowska A (2000). Reinstatement of ethanol seeking in rats: behavioral analysis. Pharmacol Biochem Behav 66: 123-128.
2. Bienkowski P, Krzascik P, Koros E, Kostowski W, Scinska A, Danysz W (2001). Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. Eur J Pharmacol 413: 81-89.
3. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S et al (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873-874.
4. Chiamulera C, Valerio E, Tessari M (1995). Resumption of ethanol-seeking behaviour in rats. Behav Pharmacol 6: 32-39.
5. Ciccocioppo R, Angeletti S, Weiss F (2001). Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. Alcohol Clin Exp Res 25: 1414-1419.
6. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I et al (1999). 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38: 1493-1503.
7. Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G et al (2001). Selective involvement of mGluR1 receptors I corticostriatal LTD. Neuropharmacology 40: 839-846.
8. Harris BR, Prendergast MA, Gibson DA, Rogers DT, Blanchard JA, Holley RC et al (2002). Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 26: 1779-1793.
9. Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A (2002). The mGluR5 antagonist, but not the mGluR2/3 agonist LY314582, augments PCP effects in prepulse inhibition and locomotor activity. Neuropharmacology 43: 1199-1209.
10. Hermans E, Challiss RA (2001). Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J 359: 465-484.
11. Hölter SM, Danysz W, Spanagel R (1996). Evidence for anticraving properties of memantine. Eur J Pharmacol 314: R1-R2.
12. Hölter SM, Danysz W, Spanagel R (2000). Novel uncompetitive N-methyl-D-Aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 292: 545-552.
13. Hölter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R, Spanagel R (1998). Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol 9: 41-48.
14. Katner SN, Magalong JG, Weiss F (1999). Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20: 471-479.
15. Kotecha SA, Jackson MF, Al-Mahrouki AA, Roder JC, Orser BA, MacDonald JF (2003). Co-stimulation of mGluR5 and NMDA receptors is required for potentiation of excitatory synaptic transmission in hippocampal neurons. J Biol Chem 278: 27742-27749.
16. Kozela E, Pilc A, Popik P (2003). Inhibitory effects of MPEP, an mGluR5 antagonist and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165: 245-251.
17. Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y (1999). Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21: 435-444.
18. Lê AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y (1998). Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135: 169-174.
19. Lê AD, Shaham Y (2002). Neurobiology of relapse to alcohol in rats. Pharmacol Ther 94: 137-156.
20. Liu X, Weiss F (2002). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22: 7856-7861.
21. Lu XY, Ghasemzadeh MB, Kalivas PW (1999). Expression of glutamate receptor subunit/subtype messenger RNAS for NMDAR1, GluR1, GluR2 and mGluR5 by accumbal projection neurons. Mol Brain Res 63: 287-296.
22. McGeehan AJ, Olive MF (2003). The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47: 240-242.
23. Oleary DM, Movsesyan V, Vicini S, Faden AI (2000). Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol 131: 1429-1437.
24. Paterson NE, Semenova S, Gasparini F, Markou A (2003). The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167: 257-264.
25. Pilc A, Klodzinska A, Branski P, Nowak G, Palucha A, Szewczyk B et al (2002). Multiple MPEP administrations evoke anxiolytic-and antidepressant-like effects in rats. Neuropharmacology 43: 181-187.
26. Popik P, Wrobel M (2002). Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43: 1210-1217.
27. Rodd-Henricks ZA, McKinzie DL, Edmundson VE, Dagon CL, Murphy JM, McBride WJ et al (2000). Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats. Alcohol 21: 73-85.
28. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pool AN, Olney JW (1995). Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469.
29. Schachtman TR, Bills C, Ghinescu R, Murch K, Serfozo P, Simonyi A (2003). MPEP, a selective metabotropic glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats. Behav Brain Res 141: 177-182.
30. Schoepp DD, Conn PJ (1993). Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14: 13-20.
31. Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M (2001). The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41: 1-7.
32. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168: 3-20.
33. Sharko AC, Hodge CW (2003). Involvement of metabotropic glutamate receptors subtype 5 (mGlu5) in ethanol-induced sedation. Alcohol Clin Exp Res S 27: 97A.
34. Sharko AC, Kimberly I, Koenig H, Lau K, Ou CJ, Olive MF et al (2002). Involvement of metabotropic glutamate receptor subtype 5 (mGluR5) in alcohol self-administration. Alcohol Clin Exp Res S 26: 112A.
35. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993). Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163: 53-57.
36. Sinclair JD (1971). The alcohol-deprivation effect in monkeys. Psychonom Sci 25: 21-24.
37. Sorensen SD, Conn PJ (2003). G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression. Neuropharmacology 44: 699-706.
38. Spanagel R (2000). Recent animal models of alcoholism. Alcohol Res Health 24: 124-131.
39. Spanagel R, Bienkowski P (2002). Glutamatergic mechanisms in alcohol dependence and addiction. In: Lodge D, Danysz W, Parsons CG (eds). Therapeutic Potential of Ionotropic Glutamate Receptor Antagonists and Modulators. Graham Publishing Co.: Johnson city, TN, USA. pp 375-403.
40. Spanagel R, Hölter SM (1999). Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcohol 34: 231-243.
41. Spanagel R, Hölter SM (2000). Pharmacological validation of a new animal model of alcoholism. J Neural Transm 107: 669-680.
42. Spanagel R, Zieglgänsberger W (1997). Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59.
43. Spooren WP, Gasparini F, Salt TE, Kuhn R (2001). Novel allosteric antagonists shed light on mGlu(5) receptors and CNS disorders. Trends Pharmacol Sci 22: 331-337.
44. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R et al (2001). Potential anxiolytic-and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132: 1423-1430.
45. Tsai G, Coyle JT (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173-184.
46. Vosler PS, Bombace JC, Kosten TA (2001). A discriminative two-lever test of dizocilpine's ability to reinstate ethanol-seeking behavior. Life Sci 69: 591-598.
47. Wang JQ, Mao L, Parelkar NK, Tang Q, Liu Z, Sarwar S et al (2003). Glutamate-regulated behavior, transmitter release, gene expression and addictive plasticity in the striatum: roles of metabotropic glutamate receptors. Curr Neuropharmacol 1: 1-29.
48. Weiss F, Porrino LJ (2002). Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 22: 3332-3337.